Prasugrel-d4

• CAT Number: R068200
• Molecular Formula: C20H16D4FNO3S
• Molecular Weight: 377.47
• Purity: ≥95%
• Storage: RT
• IUPAC Name: [5-[1-(2-fluorophenyl)-2-oxo-2-(2,2,3,3-tetradeuteriocyclopropyl)ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
• InChI: InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3/i6D2,7D2
• InChIKey: DTGLZDAWLRGWQN-KXGHAPEVSA-N
• SMILES: [2H]C1(C(C1([2H])[2H])C(=O)C(C2=CC=CC=C2F)N3CCC4=C(C3)C=C(S4)OC(=O)C)[2H]

Prasugrel-d4（Cat No.:R068200） is a deuterated analog of Prasugrel, a potent antiplatelet medication, modified with four deuterium atoms. This isotopic enhancement increases molecular stability and facilitates precise detection during analytical studies, particularly mass spectrometry. Used predominantly in pharmacokinetic and drug metabolism research, Prasugrel-d4 helps in understanding the drug’s behavior and transformations within the body. It is essential for optimizing dosage regimens and enhancing therapeutic efficacy. For researchers focusing on cardiovascular treatments, Prasugrel-d4 provides a reliable tool for detailed studies on antiplatelet therapy mechanisms.